// App-Quantinova.ai

T4308 2015 AHA : Duration of Dual Antiplatelet Therapy After Various Drug Eluting Stent Implantation

Researchers

Presenter

  • Manabu Nagao

Principal Investigators

  • Samin K Sharma

  • Akash Garg

  • Ajay Vallakati

  • Rene R Packard

  • Gregg Stone

  • Debabrata Mukherjee

  • Carl Lavie

  • Jonathan D Marmur

Medical Centers

  • Columbia Univ Medical Ctr and Cardiovascular Res Fndn, New York, NY

  • El Paso, Texas Tech Univ, TX, El Paso, TX

  • John Ochsner Heart and Vascular Institute, Ochsner Clinical School-the University of Queensland School of Medicine, New Orleans, LA

  • State University of New York Downstate Medical Center, Valley Stream, NY

  • Mount Sinai Medical Ctr, Heart & Vascular Inst, Icahn Sch of Med at Mount Sinai, New York, NY

  • James J Peters VA Medical Center, Mount Sinai School of Medicine, New York, NY

  • Metrohealth Medical Center, Case Western Reserve University, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

  • Paclitaxel

  • Rapacan

  • TAXUS

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved